Reperfusion may cause intramyocardial hemorrhage (IMH) by extravasation of erythrocytes through severely damaged endothelial walls. The purpose of the study was to evaluate the clinical significance of IMH in relation to infarct size, microvascular obstruction (MVO) and function in patients after primary percutaneous intervention. Forty-five patients underwent cardiovascular MR imaging (CMR) 1 week and 4 months after primary stenting for a first acute myocardial infarction. T2-weighted spin-echo imaging (T2W) was used to assess infarct related edema and IMH, and delayed enhancement (DE) was used to assess infarct size and MVO. Cine CMR was used to assess left ventricular volumes and function at baseline and at 4 months follow-up. In 22 (49%) patients, IMH was detected as areas of attenuated signal in the core of the high signal intensity region on T2W images. Patients with IMH had larger infarcts, higher left ventricular volumes and lower ejection fraction. Contrast-to-noise ratio (CNR) between hyperintense periphery and the hypo-intense core of the T2W ischemic area correlated to peak CKMB, total infarct size and MVO size. Using univariable analysis, CNR predicted ejection fraction at baseline (β = −0.62, P = 0.003) and follow-up (β = −0.84, P < 0.001). However, after multivariable analysis, baseline ejection fraction and presence of MVO were the only parameters that predicted functional changes at follow-up. IMH was found in the majority of patients with MVO after reperfused myocardial infarction. It was closely related to markers of infarct size, MVO and function, but did not have prognostic significance beyond MVO.
Similar content being viewed by others
Timely reperfusion is the only way to preserve ischemic myocardium in acute myocardial infarction. However, reperfusion also induces new pathological changes that were not seen in the pre-interventional era . Microvascular obstruction (MVO) or no-reflow refers to the small vessel changes that prevent adequate tissue perfusion despite a revascularized and patent epicardial coronary artery [2, 3]. Although MVO is related to infarct size, it is an independent and powerful predictor of adverse outcome [4, 5]. Reperfusion may also cause intramyocardial hemorrhage (IMH) by extravasation of erythrocytes through severely damaged endothelial walls [6, 7]. IMH can be visualized by T2-weighted CMR because breakdown products of hemoglobin are paramagnetic and influence regional magnetic tissue properties [8, 9]. Previous studies found IMH in about one-third of patients and suggested a relation with more severe myocardial injury and MVO [10, 11]. However, the exact significance of IMH and its relation to MVO remain unclear.
This study was undertaken to further evaluate presence and clinical significance of IMH by exploring its relation to infarct size, MVO and function in patients after primary coronary angioplasty for acute myocardial infarction.
All patients gave informed consent to the study protocol, which was approved by the local ethics committee. Patients were considered study candidates when admitted with a first ST-elevation acute myocardial infarction treated with successful primary coronary angioplasty (PCI) with stent implantation, defined as thrombolysis in myocardial infarction (TIMI) flow grade 2 or 3. Patients with hemodynamic instability or (relative) contraindications for CMR were excluded.
Cardiac magnetic resonance imaging protocol
All examinations were performed on a 1.5-T clinical scanner (Sonata/Symphony, Siemens, Erlangen, Germany) using a phased array cardiac receiver coil. The baseline scan was scheduled between 2 and 9 days after reperfusion and follow-up at 4 months. ECG-gated images were acquired during end-expiration breath holding. Segmented steady state free precession cine imaging (average voxel size 1.6 × 1.9 × 5 mm3, temporal resolution 47 ms) was used to evaluate left ventricular function in long axis views and full coverage short axis views (interslice gap 5 mm). Prior to contrast injection, breath-hold, segmented T2-weighted spin-echo imaging (T2W) (STIR, TR = 2 × RR-interval, TE 64 ms, average voxel size 1.4 × 1.9 × 7 mm3) was performed to visualize infarct related edema and hemorrhage. Three long axis views and a short axis view at the core of the infarct, defined as the short axis slice position with the largest circumferential amount of wall motion abnormalities were acquired . An image normalisation filter was used to correct for coil inhomogeneity. Delayed enhancement (DE) images were acquired using a segmented inversion recovery gradient-echo pulse sequence (average voxel size 1.4 × 1.7 × 5 mm3, trigger pulse 2, inversion time 250–300 ms) 12–15 min after i.v. administration of 0.2 mmol/kg gadolinium-DTPA in short axis views with slice positions copied from the cine series.
All CMR data were analysed on a separate workstation using dedicated software (Mass version 2006beta, Medis, Leiden, the Netherlands). Cine, T2W and contrast images were analysed separately, and, during analysis of one technique, the observers were blinded to results of the other techniques as well as to other clinical patient data. Endocardial and epicardial contours were manually drawn on all end-diastolic and end-systolic cine images to calculate normalised (body surface area) left ventricular end-diastolic (EDV) and end-systolic volumes (ESV), mass and ejection fraction. T2W images were assessed qualitatively for the presence of regional high signal intensity. IMH was considered present on T2W if regions of low (attenuated) signal were seen within the high signal area. Using the short axis view, the high signal intensity area (T2W infarct area) was quantified after windowing the images at mean + 2 SD of the signal intensity (SI) of remote, normal myocardium, and expressed as a percentage of total slice area. IMH was included in the calculation of T2W infarct area. An ellipsoid region of interest (0.2–0.3 cm2) was placed in the central part (core) of the T2W infarct, covering the region with attenuated signal when present, and placed in the middle of the hyperintense region in patients without IMH. Regions of interest were also drawn in the peripheral part (peri) of the T2W infarct area and in remote, normal myocardium (Fig. 1). Signal-to-noise ratio (SNR) was calculated as SNRcore = SIcore/SDnoise, and SNRperi = SIperi/SDnoise and SNRnorm = SInorm/SDnoise, respectively. Since no parallel imaging was used, noise was calculated as the standard deviation of a region of interest in background air, divided by 0.7, taking into account the number of effective radiofrequency coils. Contrast-to-noise ratio (CNR) between the infarct periphery and core was calculated as CNR = (SIperi − SIcore)/SDnoise. DE images were analysed as previously described . Total infarct size was expressed as percentage of total left ventricular mass. MVO was defined as any region of hypoenhancement within the hyperenhanced, infarcted area, and was included in the calculation of total infarct size. MVO size was calculated by subtraction of the hyperenhanced area from the total infarct size, and expressed as a percentage of left ventricular mass (%). For direct comparison of infarct extent with T2W images, infarct area in the same slice position was quantified and expressed as percentage of total slice area.
Data are expressed as mean ± SD for continuous variables. The independent samples t test and Chi-square test were used to compare subgroups. The paired samples t test was used to evaluate changes in left ventricular global parameters between baseline and follow-up. Pearson’s correlation coefficients (r) were calculated for the relation between CNR, peak CKMB, total infarct size, MVO size and ejection fraction. Univariable and multivariable linear regression analysis was used to evaluate the relation of clinical (age, CKMB) and CMR parameters (total infarct size, MVO, CNR) to ejection fraction and their ability to predict changes at follow-up.
Fifty consecutive patients were included in the study protocol. T2W image quality was non-diagnostic in both short axis and long axis views in 5 (10%) because of artifacts or regional signal loss caused by cardiac or respiratory motion. The remaining 45 patients had an uncomplicated clinical course between both CMR examinations. Mean time between admission and baseline CMR was 5.1 ± 2.1 days. Mean total infarct size was 17.6 ± 10.0% of total left ventricular mass. MVO was identified on contrast images in 27 patients (60%), and mean MVO size was 6.0 ± 8.4% of total infarct size. Mean ejection fraction was 42 ± 10%, and increased to 45 ± 10% at follow-up (P = 0.004).
Edema, hemorrhage and MVO
In all patients, T2W revealed a region of high signal intensity in the distribution area of the infarct related artery (Fig. 1). In almost half (22 of 45), areas of varying size of lower signal intensity could be identified in the central part of the area of high signal intensity (Fig. 1). Baseline characteristics according to presence of IMH are summarized in Table 1.
All patients with IMH had MVO on contrast images and only five patients with MVO did not have IMH on T2W. At baseline, patients with IMH had higher peak CKMB, larger total infarct size, larger volumes and lower ejection fraction. At follow-up, patients without IMH showed a significant improvement in EDV (89 ± 22 vs. 83 ± 22 ml/m2, P = 0.05), ESV (49 ± 17 vs. 43 ± 15 ml/m2, P = 0.003) and ejection fraction (46.4 ± 8.4 vs. 49.6 ± 8.0%, P = 0.04). Patients with IMH showed a non-significant increase in EDV (104 ± 22 vs. 111 ± 29 ml/m2, P = 0.076) and ESV (65 ± 19 vs. 67 ± 24 ml/m2, P = 0.310), and a small, non-significant increase in ejection fraction (38.9 ± 8.1 vs. 40.6 ± 8.5%, P = 0.72).
SNR and CNR analysis
Five additional patients were excluded from further signal intensity analysis because the short axis images were of insufficient quality to calculate T2W infarct area or SNR. In the remaining 40 patients, there was a significant correlation between mean infarct area on T2W images and on DE images (r = 0.73, P < 0.001), although the area was larger on T2W images: 49.3 ± 15% vs. 28.9 ± 15.7%, P < 0.001 (Fig 1). SNRperi was significantly higher than SNRcore in the patients with MVO (29.4 vs. 20.6, P < 0.001) but not in patients without MVO (29.9 vs. 30.2, P = 0.68). As a result, CNR was higher in patients with MVO than in patients without MVO (8.8 ± 5.5 vs. 0.3 ± 3.5, P < 0.001). CNR correlated significantly with peak CKMB (r = 0.51, P = 0.001), total infarct size (r = 0.57, P < 0.001), and size of the MVO area (r = 0.52, P < 0.001).
Hemorrhage and ejection fraction
Using univariable analysis, CNR strongly predicted ejection fraction at baseline (β = −0.62, P = 0.003) and follow-up (β = −0.84, P < 0.001), but not the change over time (β = −0.22, P = 0.11). After multivariable analysis, infarct size remained the single independent predictor of ejection fraction at baseline (β = −0.69, P < 0.001) and follow-up (β = −0.73, P < 0.001), whereas baseline ejection fraction and presence of MVO were the only predictors of change in ejection fraction (β = −0.29 and β = −4.99, respectively, P < 0.01).
Our study showed that intramyocardial hemorrhage can be found in almost half of patients with successfully revascularized acute myocardial infarction. The presence of IMH was associated with larger infarcts, presence of MVO, higher left ventricular volumes and lower ejection fraction, and the lack of improvement at follow-up. Contrast-to-noise ratio between (attenuated) core and (high) peripheral T2W signal intensity was strongly related to markers of infarct size, MVO and function. However, in our study, it was not an independent predictor of functional changes at follow-up.
T2-weighted imaging, edema and hemorrhage
Normal myocardium has low to intermediate signal on T2W images, but increased regional water content, such as infarct related edema, causes an increase in the T2-relaxation time and T2W signal intensity . Hemorrhage and the breakdown of oxygenated hemoglobin also influence magnetic properties of the surrounding tissue. The effects of hemoglobin degradation have been extensively studied in patients with cerebral hemorrhage; they are complex and strongly dependent on the age of the hematoma and the integrity of the erythrocyte membrane . T2W signal is high in the very early, hyperacute phase, but then falls because of the paramagnetic effects of deoxyhemoglobin and intracellular methemoglobin . Especially in the core of the hematoma, where there is marked hypoxia, signal may remain very low for a prolonged period of time . Lotan et al. studied IMH in a canine myocardial infarction model using ex-vivo T2W . They found areas of low signal within the zone of increased signal that accurately matched the location of macroscopic hemorrhage in all animals but one (with a very small hemorrhage), and no hypointense T2W regions in the animals without hemorrhage. Hemorrhage size according to CMR correlated closely to size determined from tissue slices and according to labeled red blood cells. Basso et al. recently compared in vivo and ex-vivo CMR to histopathological findings in two patients that had died 12 and 24 days after percutaneous revascularization, respectively . Both patients had hemorrhagic infarcts, with massive bleeding at the core of the infarct. Both in vivo and ex-vivo T2W showed areas of low signal intensity within areas of high signal intensity that corresponded to hemorrhage and edema, respectively. Thus, although we have no direct proof of the presence of hemorrhage in our patients, we believe that these studies sufficiently show that hemorrhage and hemoglobin breakdown leads to T2W signal attenuation as documented in our study. Our results are roughly in line with the results from previous studies that used T2*(‘star’)-weighted gradient-echo techniques to visualize IMH [10, 11]. Asanuma et al. found IMH in 9 of 24 (38%) patients with reperfused anterior MI . Patients with IMH had larger enzymatic infarct size, more Q-wave infarctions and less improvement in echocardiographic wall motion score. Ochiai et al. showed IMH in 13 of 39 (33%) patients with reperfused infarction, and also found an association between IMH, infarct severity and less improvement of ventriculographic ejection fraction . There are no studies comparing T2W spinecho imaging to T2*-weighted gradient-echo imaging for the assessment of IMH, and, at this point, it is not clear which is the optimal technique for its visualisation. Cardiac application of both techniques has been validated in a limited number of experimental and pathological studies [9, 11, 18]. Although T2*-weighted gradient-echo imaging is very sensitive to the paramagnetic effects of the deoxyhemoglobin and methemoglobin, it requires relatively long echo times that may degrade image quality during cardiac imaging . T2W spinecho imaging has the advantage that it also depicts infarct related edema, which has been shown to correspond to the area at risk [19, 20]. In line with a recent report by Friedrich et al., we found that mean (single slice) T2W infarct area was (approximately 70%) larger than DE infarct area .
Hemorrhagic myocardial infarction was rarely seen in autopsy studies in the pre-reperfusion era, but its reported incidence markedly increased after the introduction of thrombolytic therapy [6, 21]. Later studies showed that it also occurred after primary PCI [10, 11]. The appearance of hemorrhage therefore depends on the coexistence of myocardial reperfusion and microvascular damage in the setting of severe myocardial ischemia [7, 17]. The large majority (81%) of our patients with MVO also had IMH, and MVO size in the 5 patients without IMH was very small (< 1% of total infarct size). Further more, our results suggest that hemorrhage severity, as reflected by the degree of T2W signal attenuation as contrast-to-noise ratio, is related to infarct and MVO extent, but does not have prognostic value beyond MVO. In early studies in the mid-seventies, Kloner et al. already demonstrated that extravasation of erythrocytes is one of the morphological features found in areas of no-reflow . This close relation between MVO and IMH might explain the lack of additional prognostic significance as seen in our study. Figure 2 illustrates the co-existence of edema, IMH and MVO in a patient who died 3 days after inferoposterior myocardial infarction (patient was not included in the study group).
The non-invasive assessment of IMH by CMR might be used to indicate infarct severity and underlying microvascular injury, e.g. in patients with (moderate to severe) renal insufficiency, who have a relative contra-indication against the use of gadolinium compounds . However, further study is needed to define the optimum CMR technique to assess IMH, and to determine the exact role of IMH in the myocardial healing process.
Spatial coverage of the T2W images was limited as we focused on the identification of hemorrhage in the core of the infarct. As a result, we may have missed regions of signal attenuation in adjacent slices in the five patients with MVO but without IMH.
Signal-to-noise ratios are related to scan parameters such as voxel size, and therefore our results may not be directly applicable when other scanners are used.
The current breath-hold T2W spin-echo imaging technique is limited by its sensitivity to artifacts caused by cardiac or respiratory motion, as illustrated by the considerable number of non-diagnostic images in our study group (10% of long axis images, 20% of short axis images). A recently proposed adaptation of the technique to optimize performance has not yet been evaluated in a clinical setting .
Intramyocardial hemorrhage was found in the majority of patients with microvascular obstruction after percutaneous revascularization for acute myocardial infarction. It was closely related to markers of infarct size, MVO and function, but, in this study, did not have prognostic significance beyond MVO.
Pasotti M, Prati F, Arbustini E (2006) The pathology of myocardial infarction in the pre- and post-interventional era. Heart 92:1552–1556
Ambrosio G, Weisman HF, Mannisi JA et al (1989) Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation 80:1846–1861
Reffelmann T, Kloner RA (2002) The “no-reflow” phenomenon: basic science and clinical correlates. Heart 87:162–168
Wu KC, Zerhouni EA, Judd RM et al (1998) Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 97:765–772
Nijveldt R, Beek AM, Hirsch A et al (2008) Functional recovery after acute myocardial infarction: a comparison between angiography, electrocardiography and cardiovascular magnetic resonance measures of microvascular injury. J Am Coll Cardiol 52:181–189
Fujiwara H, Onodera T, Tanaka M et al (1986) A clinicopathologic study of patients with hemorrhagic myocardial infarction treated with selective coronary thrombolysis with urokinase. Circulation 73:749–757
Basso C, Thiene G (2006) The pathophysiology of myocardial reperfusion: a pathologist’s perspective. Heart 92:1559–1562
Bradley WG Jr (1993) MR appearance of hemorrhage in the brain. Radiology 189(1):15–26
Lotan CS, Bouchard A, Cranney GB et al (1992) Assessment of postreperfusion myocardial hemorrhage using proton NMR imaging at 1.5 T. Circulation 86:1018–1025
Asanuma T, Tanabe K, Ochiai K et al (1997) Relationship between progressive microvascular damage and intramyocardial hemorrhage in patients with reperfused anterior myocardial infarction: myocardial contrast echocardiographic study. Circulation 96:448–453
Ochiai K, Shimada T, Murakami Y et al (1999) Hemorrhagic myocardial infarction after coronary reperfusion detected in vivo by magnetic resonance imaging in humans: prevalence and clinical implications. J Cardiovasc Magn Reson 1:247–256
Simonetti OP, Finn JP, White RD et al (1996) “Black blood” T2-weighted inversion-recovery MR imaging of the heart. Radiology 199:49–57
Constantinides CD, Ergin A, McVeigh E (1997) Signal-to-noise measurements in magnitude images from NMR phased arrays. Magn Reson Med 38:852–857
Nijveldt R, Beek AM, Hofman MBM et al (2007) Late gadolinium-enhanced cardiovascular magnetic resonance evaluation of infarct size and microvascular obstruction in optimally treated patients after acute myocardial infarction. J Cardiovasc Magn Reson 9:765–770
Higgins CB, Herfkens R, Lipton MJ et al (1983) Nuclear magnetic resonance imaging of acute myocardial infarction in dogs: alterations in magnetic relaxation times. Am J Cardiol 52:184–188
Parizel PM, Makkat S, Van Miert E et al (2001) Intracranial hemorrhage: principles of CT and MRI interpretation. Eur Radiol 11:1770–1783
Basso C, Corbetti F, Silva C et al (2007) Morphologic validation of reperfused hemorrhagic myocardial infarction by cardiovascular magnetic resonance. Am J Cardiol 100:1322–1327
van den Bos EJ, Baks T, Moelker AD et al (2006) Magnetic resonance imaging of hemorrhage within reperfused myocardial infarcts: possible interference with iron oxide-labelled cell tracking? Eur Heart J 27:1620–1626
Aletras AH, Tilak GS, Natanzon A et al (2006) Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. Circulation 113:1865–1870
Friedrich MG, Abdel-Aty H, Taylor A et al (2008) The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. J Am Coll Cardiol 51:1581–1587
Mathey DG, Schofer J, Kuck KH et al (1982) Transmural, hemorrhagic myocardial infarction after intracoronary streptokinase. Clinical, angiographic, and necropsy findings. Br Heart J 48(6):546–551
Kloner RA, Ganote CE, Jennins RB et al (1975) Demonstration of the “no-reflow” phenomenon in the dog heart after temporary ischemia. Recent Adv Stud Cardiac Struct Metab 10:463–474
Kuo PH, Kanal E, Abu-Alfa AK et al (2007) Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology 242:647–649
Keegan J, Gatehouse PD, Prasad SK et al (2006) Improved turbo spin-echo imaging of the heart with motion-tracking. J Magn Reson Imaging 24:563–570
The authors would like to thank Paul Algra, MD, PhD (department of Radiology, Medical Center, Alkmaar, The Netherlands), Victor Umans, MD, PhD (department of Cardiology Medical Center, Alkmaar, The Netherlands) and Mary Belderok (department of Cardiology, VU University Medical Center, Amsterdam) for their contribution to the patient group collection and the data acquisition. The authors would also like to thank Hans Niessen, MD, PhD (department of Pathology, VU University Medical Center, Amsterdam, The Netherlands) for providing Fig. 2. This study was supported by Netherlands Heart Foundation grant 2003B126.
This study was approved by the local ethics committee. Written informed consent was obtained from all patients.
This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
About this article
Cite this article
Beek, A.M., Nijveldt, R. & van Rossum, A.C. Intramyocardial hemorrhage and microvascular obstruction after primary percutaneous coronary intervention. Int J Cardiovasc Imaging 26, 49–55 (2010). https://doi.org/10.1007/s10554-009-9499-1